Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-26

FDA Approved: CARISOPRODOL — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for carisoprodol filed by Chartwell RX, LLC. This action confirms regulatory approval for the muscle relaxant under the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carisoprodol (Carisoprodol)

Snippet

SUPPL AP for CARISOPRODOL (CARISOPRODOL)